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Abstract 
Development of influenza vaccine processes requires virus quantification to optimize conditions in cell culture or in the associated 
downstream purification steps. Modern methods include qPCR, which utilizes TaqMan chemistry to detect and quantify viral RNA 
by comparison of a RNA standard of known concentration. Digital droplet PCR (ddPCR) is similar to qPCR in that it shares the 
same chemistry for nucleic acid detection. However, in ddPCR, the sample is diluted into partitions (‘droplets’) in order to separate 
and isolate single molecules. Upon PCR amplification, the droplet’s fluorescent intensity depends on the presence or absence of 
the target; as such, positive and negative droplets are identified, which allows for absolute quantification of the viral genomes.  The 
digital approach has enabled several key advantages. First, a standard is no longer required. Second, efficiency of the reverse 
transcription and the kinetics of the amplification, principles in qPCR, have no impact on the final digital PCR quantification. For 
this reason, the extracted RNA does not need to be purified from the reagents needed to lyse the virus. Also, viral associated RNA 
released by infected cells can be measured directly, further improving the quality of the data generated. Additional improvements 
to the approach include duplexing with a second assay that measures host cell DNA concentration. The method has been 
successfully implemented with automation in support of multiple upstream and downstream process development efforts for 
influenza vaccine manufacturing. 
© 2015 The Authors. Published by Elsevier B.V. 
Selection and peer-review under responsibility of the 8th Vaccine Conference Organizing Committee. 
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1. Introduction 
Viral titers are commonly determined by quantification of viral genomic fragments1. One such protocol, qPCR, 
requires that viral RNA be purified and concentrated by both column, centrifugal methods and extracted from cell 
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harvest2. The recovered RNA is then retro-transcribed to cDNA and amplified by PCR. qPCR measures the cycle 
number at which the fluorescence, produced by a TaqMan probe, crosses a threshold identified as ‘crossing point’ or 
Ct value. A standard curve is generated by an independent serial dilution of known in vitro transcribed RNA 
(quantification of the standard RNA is based on optical density). The RNA concentration of the sample is extrapolated 
by comparing the Ct value of the sample and the Ct of the standard3. The precision of the assay is limited by the nature 
of the Ct determination (where precision is defined by ± one PCR cycle); the resulting value has a relative standard 
deviation that can exceed 50%. In addition, the assay workflow is complex with several steps introducing possibility 
for error including sample preparation, concentration, column RNA purification, and use of the RNA standard. 
Moreover, results obtained over time, using different instruments and standards are not comparable. 
Digital droplet PCR (ddPCR) is similar to qPCR in that the approach is based on the detection of the amount of 
cDNA with a TaqMan probe, but the amplification is detected by a different method. The sample is diluted into 
partitions (‘droplets’) in order to separate and isolate single molecules (Figure 1A-B). A Poisson distribution analysis 
is used to determine the number of template molecules in a droplet. The value of ln(1-p), where p is the fraction of 
positive droplets, determines the number of target copies per droplet and thus the number of copies of target molecules 
in a 20 ђl sample. Upon PCR amplification, the partitions with a fluorescent signal indicate the presence of the target 
(Figure 1C-D). The signal is generated by cleavage of a TaqMan probe, which has been designed to target the matrix 
(M) gene fragment of the viral RNA4. The first advantage of the ddPCR approach over qPCR is that absolute 
quantification is possible, so a standard is no longer required. Second, ddPCR only detects the presence or absence of 
the target; although the signal is generated by endpoint PCR, some degree of efficiency is required in order to 
distinguish the positive drops from the background. Efficiency of the reserve transcription impacts absolute 
quantification, as a genome that fails to be reverse-transcribed does not produce a positive signal. For this reason, the 
extracted RNA does not need to be purified from the reagents needed to lyse the virus. As a result, the workflow is 
greatly simplified; a lysis buffer is added directly to the cell supernatant (Figure 2A), then the material is diluted, 
mixed with the PCR reaction, divided into droplets, and the starting RNA material is amplified. The ‘digital’ signal 
entails the counting of the positive droplets, performed by a fluorimeter, which effectively measures the number of 
RNA molecules present in the sample directly.   
During the development of an influenza cell culture process, we were also interested in measuring cell lysis to 
determine whether other strains of influenza viruses might behave differently in cell culture at large volumes. Cellular 
lysis had an important impact during vaccine manufacturing in particular due to the release of genomic DNA. Large 
amounts of DNA caused difficulties in the downstream process and the ability to purify the antigen product from 
contaminants. Measuring DNA levels in the cell supernatant was challenging due to the complexity of the sample. 
PicoGreen has been a common technique used to develop downstream processes, but it could not be used for measuring 
DNA in the cell supernatant as the assay suffered from matrix interference. As part of this work, we developed and 
implemented a ddPCR protocol for DNA quantification in the harvest. Eukaryote genomes contain a high proportion 
Figure 1. Digital Droplet PCR. Single molecules are isolated in separate partitions (A: Bio-Rad ddPCR system (20,000 droplets) concept in 
which a greater total number of droplets results in higher accuracy for Poisson-based counting, B: partitions created by emulsion, images 
provided courtesy of Bio-Rad Laboratories, Inc.). Upon PCR amplification, the droplets with a fluorescent signal indicate the presence of the 
target molecule. The ‘digital’ signal entails the counting of the positive and negative droplets, performed by a fluorimeter (C: single molecule 
detection on serially diluted samples. D: quantification from the three dilutions highlighted in C). 
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of repetitive elements that can be grouped into tandemly 
repeated DNA or interspersed repetitive DNA. SINEs (short 
interspersed elements) belong to the latter classification 
(Figure 2B). They have a size less than 500 bp and are 
distributed in a high copy number throughout the genome. 
The repetitive element SINE_CF is specific for the canine 
genome5-6. Due to the high copy number (>1000 copies per 
haploid genome), detection of SINE DNA sequences is much 
more sensitive than detection of conventional, relatively low 
copy number, gene sequences. We developed a digital PCR 
assay that detected canine SINE elements. The assay detected 
very small amounts of DNA and allowed for determination 
of small variation in DNA amounts within sample sets. The 
assay was duplexed with the virus quantification digital PCR 
assay using TaqMan probes with non-overlapping 
fluorescence. The digital PCR analysis produced absolute 
quantifications of the viral titers and DNA levels in a given 
sample. 
2. Materials and Methods 
2.1. Materials 
T100 Thermal Cycler (Bio-Rad), QX100 Droplet 
Generator (Bio-Rad), QX100 Droplet Reader (Bio-Rad) - 
Software Bio-Rad Quanta Soft v. 1.2.10.0., PX1 PCR Plate 
Sealer (Bio-Rad), Droplet Reader Oil (Bio-Rad), Droplet 
Generator Oil (Bio-Rad), DG8 Cartridge Holder (Bio-Rad), 
DG8 Cartridges for QX100™ Droplet Generator (Bio-Rad), 
DG8 Gaskets for QX100™ Droplet Generator (Bio-Rad), 
Pierceable Foil Heat Seal (Bio-Rad), PCR tubes strips 0.2 
ml. (Eppendorf), Semi-skirted 96 well PCR plates. 
2.2. Reagents 
Water nuclease free (Thermo Scientific), Tube Biopur 
Safelock 1.5ML CS100, QIAamp Viral RNA Kit 
(QIAGEN), One-Step RT-ddPCR Kit for Probes (Bio-Rad). 
Influenza A, M segment, digital PCR assay: Forward primer 
influenza A "d_InfAM_BR18" Nucleotide sequence: 5`-
CAGGCCCCCTCAAAGC-3´ (IDT, purification: HPLC) Reverse primer Influenza A "d_InfAM_BR11" nucleotide 
sequence: 5`-GCGTCTACGCTGCAGTCC-3´ TaqMan probe Influenza A "d_InfA_M_TMa" nucleotide sequence:  
5'- /56-FAM/AG GTG ACA G/ZEN/G ATT GGT CTT GTC TTT AGC C/3IABkFQ/ -3'. MDCK, SINEs sequence, 
digital PCR assay: Forward primer MDCK SINEs " d_MDCK_SINEs_ FWD" Nucleotide sequence: 5'- AGG GCG 
CGA TCC TGG AGA -3' Reverse primer MDCK SINEs " d_MDCK_SINEs_ REV Nucleotide sequence: 5'- AGA 
CAC AGG CAG AGG GAG AAG -3', TaqMan probe MDCK SINEs " MDCK_ddPCR_PRB " Nucleotide sequence: 
5'- /5HEX/AT CGA ATC C/ZEN/C ACA TCA GGC TCC /3IABkFQ/ -3’, All primers and probes, IDT HPLC 
purified. Standard and positive control Extracted MDCK DNA 30ng/ђl (Life Technologies, resDNASEQ Quantitative 
MDCK DNA Kit, DNA control). The duplex assay for M sequence and MDCK DNA was a mix of 4 primers and 2 
probes; final concentrations for primers and probes were 0.4 and 0.2 ȝM respectively.  
Figure 2. Excluding non-viral associated genomes and detection 
of cellular DNA in culture supernatant. Infected cells contain 
large amounts of viral RNA. When cell lysis occurs, non-viral 
associated RNA is released in the culture supernatant in large 
quantities, and can lead to over-estimation of viral particles. Total 
RNA is quantified in a reaction in which the sample is lysed. ‘Free 
RNA’ is quantified in a separate reaction (A: measurable RNA in a 
lysed and non-lysed sample). The viral associated RNA is 
calculated based on the difference of the two values. Measuring 
MDCK (Madin-Darby canine kidney) DNA in cell supernatant is 
challenging due to matrix interference. A ddPCR assay was 
developed to select SINEs (short interspersed elements), short DNA 
sequences repeated with over 1000 copies in the canine genome (B: 
distribution of tandem elements). This approach improves the 
detection limit of the assay by about 1000 fold over a single target. 
The viral titer quantification and MDCK DNA quantification are 
‘multiplexed’ in the same assay. 
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2.3. Viral Lysis and nucleic acid extraction (Reagents from QIAamp Viral RNA Kit) 
Samples were equilibrated to room temperature. Buffer AVL (viral lysis buffer containing guanidine thiocyanate) 
was checked for precipitate, and if necessary incubated at 80°C until the precipitate was dissolved. 140 ȝL of sample 
(undiluted clarified harvest) was added to a 1.5 mL tube. 560 ȝL of Buffer AVL was added, mixed by pulse-vortexing 
for 15 s, and incubated at room temperature (15–25°C) for 10 min. The tube was briefly centrifuged to remove drops 
from the inside of the lid. 560 ȝL of ethanol (96–100%) was added to the sample and mixed by pulse-vortexing for 
15 s. The tube was briefly centrifuged to remove drops from inside the lid. The lysed virus/extracted nucleic acid was 
diluted as described and used directly in the reaction or frozen at -20°C for an application at a later date. Volumes 
were reduced if sample was limited or for high throughput assays (e.g. 14 ȝL of sample, 56 ȝL of Buffer AVL and 56 
ȝL of ethanol provided enough material for the subsequent steps). 
2.4. Preparation of ‘non-lysed’ sample 
RNA quantification of ‘non lysed’ sample was used to evaluate ‘free RNA’ (RNA originated from lysed infected 
cells) which was taken into account in the final RNA quantification. A volume of PBS equal to the combined volume 
of Buffer AVL and Ethanol was added to the sample (e.g. for 140 ȝL of sample, 1120 ȝL of 1x PBS was added). 
2.5. Quantification of ddPCR results 
Samples were diluted serially (1e2–1e8) in 1x PBS. Droplets were generated with the QX100™ Droplet Generator 
and the emulsion generated was transferred to a 96 well semi-skirted plate for PCR. Cycling program with T100 
Thermal Cycler (Bio-Rad): RT step: 60 °C, 30 minutes. Taq activation: 95°C, 5 minutes. 45 PCR cycles 
(Denaturation : 94°C, 30 seconds - Ramp 2°C/second. Annealing and extension : 59°C, 60 seconds - Ramp 
2°C/second). 98°C, 10 minutes. Hold at 4°C. QX100 Droplet Reader wavelength settings - HEX/FAM. The same 
threshold was applied to all samples and absolute concentration was reported in the table in copies per μL. For every 
sample, concentration of the ‘free RNA’ was subtracted from the total RNA (lysed sample). Dilutions for lysis, serial 
dilutions, PCR mix were accounted for to determine final concentration. 
2.6. Focus- Formation Assay (FFA), HA Titer, Virus Counter 
FFA: FFA was used as an infectious tittering assay. Clarified culture supernatants were serially diluted and applied 
to MDCK cells for 16-20 hours (single round infection). Cells were then fixed and immunostained using two mouse 
anti-NP antibodies followed by a goat anti-mouse Alex Fluor 488-conjugated antibody. Infected cells fluoresced when 
excited by light at a wavelength of 495nm, with an emission at 519nm, and were counted by a Biospot Analyzer (CTL) 
to obtain the infectious titer. HA Titer: HA of influenza has the ability to agglutinate red blood cells and this activity 
has been used as a correlate to estimate HA yield and virus titer.  In this assay, clarified culture supernatant is serially 
diluted and applied to red blood cells for 0.5-1 hour. The dilution factor directly correlates to HA yield. Virus Counter: 
The virus counter (ViroCyt, Boulder, CO) allowed for direct determination of viral titers using a fluorimeter for 
particle detection in the range of 100nm in size. A dual dye system was used to quantify particles that contained both 
protein and nucleic acids. 
3. Results 
3.1. Development of a ddPCR assay for quantification of influenza virus A 
In this ddPCR protocol, the sample was mixed with a PCR master mix, and partitioned into ‘droplets’ in such a 
way that only one target DNA molecule ‘or less’ was present in every partition. At the right dilution, some droplets 
contained one copy of the target DNA, while the majority of the droplets were empty. PCR amplification was then 
performed and the droplets that contained the targeted DNA sequence formed a product from the PCR reaction, which 
was then detected through TaqMan chemistry. A droplet reader counted the number of molecules initially partitioned, 
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effectively determining the absolute quantification in copies of target per volume unit. As opposed to qPCR (which 
requires a standard and is dependent on reaction kinetics), ddPCR is therefore a preferred method over qPCR for high 
throughput applications due to much greater precision (high reproducibility of replicates) and accuracy (absolute 
quantification).  
The assay that was developed for quantification of viral genomes accounted for only the viral associated RNA and 
excluded the RNA released by a lysed infected cell, which would have overestimated the quantification of the viral 
particles. Different approaches have been tested, including enzymatic digestion of the ‘free’ RNA that resulted in 
variable results. One challenge of the ddPCR workflow for this application was that RNA must be extracted from the 
virus to be retro-transcribed to cDNA. RNA molecules ‘protected’ by whole viruses did not generate cDNA. This limit 
was exploited to improve the accuracy of the assay. Two assays were performed for each sample: in one, a combination 
of a strong chaotropic agent (guanidinium thiocyanate) and an organic solvent (ethanol) was added to the sample, 
thereby lysing viral particles and releasing RNA in solution. The ‘total’ RNA in the cell supernatant was quantified 
by ddPCR. In a parallel workflow, lysis buffer was not applied to the sample, and only the ‘free’ RNA was quantified. 
The difference of the RNA quantification of the ‘lysed’ and ‘non-lysed’ sample was used to determine the viral titer 
in solution. After acquiring the absolute concentration measurement, the dilutions must be accounted for – 9x dilution 
in lysis (140 ђL in 1260 final), 1eX dilutions of sample (serial dilutions), 5x dilution in PCR mix (4 ђL in 20 final). 
As an example, the concentration in the original sample is 150 x9 x5 x1e4 = 6.75e7 copies/ђL = 6.75e10 copies/mL. 
The ratio of free RNA versus total RNA (% of free RNA) was an additional valuable output of the assay and was used 
as valid indication of the amount of lysed infected cells. 
3.2. Detection of cellular DNA in culture supernatant  
A digital droplet PCR assay for MDCK (Madin-Darby canine kidney) DNA was developed with the objective of 
quantifying MDCK DNA directly from MDCK cell supernatant, where other methods failed because of the complexity 
of the matrix. In this method, the sample was treated to release nucleic acids or dissolve aggregates. A dilution was 
then performed and the target DNA sequence was quantified by digital droplet PCR. Two TaqMan assays were 
initially developed for ddPCR to quantify MDCK DNA. The first assay targeted short interspersed nuclear elements 
(SINEs). These DNA sequences were unique to the Canis familiaris genome and were present in > 1000 copies per 
genome. The second assay targeted β-actin, a unique specific sequence present only twice in a diploid genome, or in 
multiple copies in a genome such as the MDCK cell line (data not shown). The advantage of the SINEs assay was 
increased sensitivity over the β-actin assay, of about 1000 fold, due to the higher amount of target present. The 
disadvantage was that not all SINEs have the exact same DNA sequence causing some droplets to show a partial 
positive signal. An arbitrary threshold needed to be applied to separate positive and negative signals. Nevertheless, 
when the assay was tested on 24 different samples, in three separate experiments, the RSD of the assay was 7.1 ± 3.6 
%, showing that the variability introduced by an arbitrary threshold had a minor impact on the precision of the assay. 
Vice versa, the advantage of the ȕ-actin assay was a clear separation of negative and positive signals, which favored 
precision and accuracy, while the disadvantage was a lower sensitivity due to the reduced number of targets.  
3.3. Automation: introducing higher throughput and precision 
In terms of workflow, digital PCR differed substantially from the qPCR setup for viral titers quantification. No 
column purification or labor intensive steps were required, so the process was able to be automated. An automatic 
liquid handler (ALH - epMotion M5073) was programmed to execute the ddPCR workflow for the duplex assay. 
Samples were provided in a multiwell plate, and the instrument performed most of the steps required for the PCR 
plate setup. Each sample was duplicated and either lysed by the serial addition of lysis buffer or, in a different well, 
diluted to the same final concentration as the lysed sample. A serial dilution was then performed in three steps to 
achieve a 1:1000 dilution from the original solution, a factor that we identified to bring most of our samples into the 
linearity range of the ddPCR assay. The instrument then proceeded with setting up the PCR reaction by mixing defined 
amounts of sample and PCR master-mix. Droplets were generated from the final samples outside the liquid handler. 
The workflow was routinely executed on sample sets up to 24 samples. Because samples were duplicated and analyzed 
as lysed and non-lysed, the number of samples processed per run added up to 48 (studying lysed and non-lysed allowed 
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us to determine non-viral associated RNA, which in turn helped to provide a very accurate determination of viral 
titers). When the lysed/non-lysed comparison wasn’t required (such as in optimized bioreactors/conditions where the 
%free RNA was consistently below LOD) up to 48 samples were processed every run. The automated workflow setup 
for 48 samples was completed in less than 1 hour. 
3.4. In depth understanding of influenza virus production kinetics through use of droplet digital PCR 
MDCK cells were cultured in shake flasks and infected with influenza virus (A/Victoria/210/2009, 
A/Brisbane/10/10, A/Minnesota/11/2010, A/Turkey/Turkey/1/2005, backbones selected from PR8X, #19, or #21)7. 
Cell supernatant was prepared by centrifugation and filtration and tested for viral titers and MDCK DNA (Figure 3A-
B). Three different media were tested and four cell densities were evaluated (1: 5e5 cells/mL, 2: 1e6 cells/mL, 3: 3e6 
cells/mL, 4: 5e6 cells/mL). Samples were taken from the bioreactor at 24, 48 and 72 hours post infection (HPI). The 
results showed the impact of different media on viral propagation. Viral titers did not increase with cell densities. 
MDCK DNA increased over time and cell density, but was not directly related to viral titers. Viral titers were within 
1e9 vp/mL and 1e10 vp/mL and even minor differences (1.2 fold) were measured due to the high precision of the 
technique.  
3.5. Viral genomes and HA mass correlation 
24 bioreactors were run in parallel in a DoE experiment with 4 different viruses (A/Brisbane/10/10, 4 backbones), 
3 MOIs (2e-4, 2e-5, 2e-6), and 3 temperatures (31°C, 32.5°C, 34°C). Viral concentration was determined by ddPCR 
(standard deviation from three technical replicates was reported in the error bars). HA mass was detected by ELISA 
as an orthogonal method for virus quantification (Figure 3C).  Correlation of ddPCR and ELISA was significant 
(Pearson’s correlation coefficient ߩ=0.87). Both methods allowed for the identification of the best condition for viral 
replication (MOI 2e-4, 34°C, backbone #21, generating 5.09e10 vp/mL and 91.7 mg/mL by ELISA). The left portion 
of the panels showed the spread of the data as measured by ddPCR, and the assay precision of four assays currently 
in use was reported on the right part of the panel (Figure 4A). ddPCR had the best precision (RSD<10%) and was 
sufficient to determine differences on this type of sample spread. FFA (Focus Forming Assay), ELISA and HA Titer 
lacked the sufficient precision to determine most of the differences within this sample set. Statistical correlation was 
studied (Pearson’s correlation coefficient ߩ indicated in table, Figure 4B). Correlation was found with ddPCR and 
ELISA, virus counter and HA titer. FFA did not correlate to any other method due to lack of precision on this specific 
spread of data. 
Figure 3. Quantification of viral titers and MDCK DNA in cell culture, viral genomes and HA mass correlation. Viral titers (y-axis) did not 
increase with cell densities - 1: 5e5  cells/mL, 2: 1e6 cells/mL, 3: 3e6 cells/mL, 4: 5e6 cells/mL (A: ddPCR quantification of viral titers). MDCK 
DNA increased over time and cell density, but was not directly related to viral titers (B: ddPCR quantification of MDCK DNA). HA mass detected by 
ELISA (C: correlation of ddPCR and ELISA).
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4. Conclusions 
We developed an innovative high throughput method for very precise and accurate influenza virus titer 
quantification. The approach offered several key advantages: the RNA did not need to be purified, avoiding several 
labor intensive steps which contributed to assay variability found with qPCR. Furthermore, complete automation was 
implemented. The ddPCR approach was an absolute quantification method without requiring a RNA standard. Viral 
associated genomes could be distinguished from RNA released by lysed infected cells, which improved the quality of 
the data generated. MDCK DNA was precisely quantified, even in the presence of a complex matrix. 
The MDCK DNA assay that gave the best results in the head to head comparison was the SINEs-ddPCR assay. 
The sample analyzed had a DNA concentration 50,000 fold higher than the lower LOQ of the assay. MDCK DNA 
stock (30ng/μL from the Life Technologies commercial kit resDNASEQ® Quantitative MDCK DNA kit) could be 
read to a dilution up to 5.00E+07, corresponding to 6e-7 ng/ μL (=0.6 pg/mL). This assay was used to quantify very 
low DNA concentrations also in the presence of high concentration of detergents, chaotropic agents or organic 
solvents. It was a very precise assay that could be automated and had a very high throughput. Comparison to other 
assays such as the DNA threshold assay had not been performed and would have been a valuable addition to the 
development of the assay. 
Figure 4. Spread of the data versus assay precision, Pearson’s correlation table. 
The left portion of the panels showed the spread of the data and the assay precision of 
four assays currently in use was reported on the right part of the panel (A: viral titers 
measured by ddPCR, FFA, ELISA, HA titer). Correlation was found with ddPCR and 
ELISA (B: correlation table, pearson coefficient). 
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The ȕ-actin ddPCR assay could be used to study samples in the experiment above, but values were much closer to 
the lower LOQ. A sample with low DNA amounts and high concentration of detergents would easily be outside the 
acceptable range (for example, a post-splitting material in the FCC process). 
PicoGreen was a very precise and accurate assay to use, but it suffered from matrix interference and low sensitivity. 
A sample such as harvest or post-splitting material had a ratio of DNA over interfering matrix components that did 
not allow reads in the acceptable range. Values that had spike recovery values (an internal control used in the assay) 
outside the dynamic range were commonly accepted for this assay, but could have largely misled the evaluation of 
the DNA concentration in the sample. 
There are some caveats of the SINEs ddPCR approach that should be considered in the analysis. If multiple SINEs 
are present in one DNA fragment, they would segregate in one droplet and would count as one. Hence, the higher the 
DNA fragmentation, the higher the number of SINEs on different molecules there would be. Samples that contain 
active benzonase or other DNAses were measured but care must be taken in interpreting the results as the enzyme was 
active throughout the sample preparation, which included changes in buffer and sample concentration. This had an 
impact on the DNA concentration measured. 
The method described has supported multiple process development efforts for synthetic seeds selection and next 
generation influenza vaccines manufacture as a much needed tool for process understanding. This is an example of 
how ddPCR technology has allowed our group to measure differences that could have not been determined by previous 
technologies. 
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